BioSpace News Archive

Deals

Nephros Announces Acquisition of GenArraytion, Inc.

Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that it has acquired substantially all of the assets of Rockville, MD-based GenArraytion, Inc.

July 12, 2021
·
3 min read
Business

Titan Medical Announces Appointment of New Chief Financial Officer

Titan Medical Inc. today announced the appointment of Stephen Lemieux as the Chief Financial Officer of the Company.

July 12, 2021
·
5 min read
BioCapital

Medcura Launches a New Class of High-Performance, Antibacterial Hemostats

Medcura, Inc. announced today the launch of a high-performance, antibacterial hemostatic gel, Rapid-Seal®, available @ https://amazon.com/rapid-seal and on the shelves at a leading US drugstore chain.

July 12, 2021
·
3 min read
BioCapital

Aditxt Launches High-Sensitivity Neutralizing Antibody Test to Detect Individual Immune Response to COVID-19

AditxtScore™ for COVID-19 Now Includes Virus-Specific Infection Blocking Antibodies that Assess the Strength of an Individual’s Immune Response to SARS-CoV-2

July 12, 2021
·
4 min read
BioMidwest

Aptinyx to Participate in William Blair Biotech Focus Conference 2021

Aptinyx Inc. today announced that Norbert Riedel, Ph.D., chief executive officer, will participate in the Updates in Neuropysch panel discussion at the William Blair Biotech Focus Conference on Thursday, July 15 at 12:00 p.m. ET.

July 12, 2021
·
1 min read
Business

Establishment Labs Announces Departure of CFO and Appointment of Raj Denhoy as Interim CFO

Establishment Labs Holdings Inc. today announced that Renee Gaeta will step down from her position as Chief Financial Officer for another opportunity outside of the company, effective July 30, 2021.

July 12, 2021
·
7 min read
FDA

Prilenia: FDA Grants Orphan Drug Designation for pridopidine for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

FDA Grants Orphan Drug Designation is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for pridopidine for the treatment of ALS.

July 12, 2021
·
4 min read
Pharm Country

Brooklyn ImmunoTherapeutics to Present at the Access to Giving Virtual Investor Conference on July 15, 2021

Brooklyn ImmunoTherapeutics LLC today announced that Chief Executive Officer Howard J. Federoff, M.D., Ph.D., will present a corporate overview at the Access to Giving Virtual Investor Conference being held July 13-15, 2021.

July 12, 2021
·
1 min read
Business

nference and Mayo Clinic Study Confirms Link Between Anemia and Rehospitalization After COVID-19 Infection Clearance

nference today announced publication of a study in iScience that analyzed Mayo Clinic data with nference artificial intelligence (AI) software to suggest that anemia-related laboratory tests should be considered in risk stratification algorithms for COVID-19 patients.

July 12, 2021
·
2 min read
FDA

Halozyme Announces Janssen Receives U.S. FDA Approval of DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) in Combination with Pomalidomide and Dexamethasone for Patients with Multiple Myeloma After First or Subsequent Relapse

Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Janssen Biotech, Inc. (Janssen) received U.S. Food and Drug Administration (FDA) approval of DARZALEX FASPRO.

July 12, 2021
·
4 min read